These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1417050)

  • 21. Fat malabsorption in cystic fibrosis patients.
    Murphy J; Laiho K; Wootton S
    Am J Clin Nutr; 1999 Nov; 70(5):943-6. PubMed ID: 10539762
    [No Abstract]   [Full Text] [Related]  

  • 22. Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid.
    Dorsey J; Buckley D; Summer S; Jandacek RJ; Rider T; Tso P; Narkewicz MR; Heubi JE
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):441-6. PubMed ID: 20179641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a medium dose of ursodeoxycholic acid with or without taurine supplementation on the nutritional status of patients with cystic fibrosis: a randomized, placebo-controlled, crossover trial.
    Merli M; Bertasi S; Servi R; Diamanti S; Martino F; De Santis A; Goffredo F; Quattrucci S; Antonelli M; Angelico M
    J Pediatr Gastroenterol Nutr; 1994 Aug; 19(2):198-203. PubMed ID: 7815243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipid, nitrogen, water and energy content of a single stool sample in healthy children and children with cystic fibrosis.
    Van den Neucker AM; Forget PP; van Kreel B
    Eur J Pediatr; 2003 Nov; 162(11):764-6. PubMed ID: 12942318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of steatocrit and fat absorption in persons with cystic fibrosis.
    Wagner MH; Bowser EK; Sherman JM; Francisco MP; Theriaque D; Novak DA
    J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):202-5. PubMed ID: 12187298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Energy balance during acute respiratory exacerbations in children with cystic fibrosis.
    Reilly JJ; Ralston JM; Paton JY; Edwards CA; Weaver LT; Wilkinson J; Evans TJ
    Eur Respir J; 1999 Apr; 13(4):804-9. PubMed ID: 10362044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Energy and nutrient intakes in cystic fibrosis.
    Buchdahl RM; Fulleylove C; Marchant JL; Warner JO; Brueton MJ
    Arch Dis Child; 1989 Mar; 64(3):373-8. PubMed ID: 2705801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Taurine decreases fecal fatty acid and sterol excretion in cystic fibrosis. A randomized double-blind trial.
    Smith LJ; Lacaille F; Lepage G; Ronco N; Lamarre A; Roy CC
    Am J Dis Child; 1991 Dec; 145(12):1401-4. PubMed ID: 1669669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Markers for faecal fat estimation in monitoring steatorrhoea in cystic fibrosis.
    Gilbert J; Kelleher J; Walters MP; Littlewood JM
    Gut; 1988 Sep; 29(9):1286-8. PubMed ID: 3198006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Intestinal absorption of fats in children using serum turbidity and triglyceride absorption tests].
    Costa CD; Schmidt BJ; de Barros FJ; Tamega I das E
    Arq Gastroenterol; 1985; 22(4):196-203. PubMed ID: 3837660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Energy content of stools in normal healthy controls and patients with cystic fibrosis.
    Murphy JL; Wootton SA; Bond SA; Jackson AA
    Arch Dis Child; 1991 Apr; 66(4):495-500. PubMed ID: 2031608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.
    Proesmans M; De Boeck K
    Eur J Pediatr; 2003 Nov; 162(11):760-3. PubMed ID: 13680386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carbohydrate malabsorption is minimal in school-age cystic fibrosis children.
    Hoffman RD; Isenberg JN; Powell GK
    Dig Dis Sci; 1987 Oct; 32(10):1071-4. PubMed ID: 3652895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excessive fecal taurine loss predisposes to taurine deficiency in cystic fibrosis.
    Thompson GN
    J Pediatr Gastroenterol Nutr; 1988; 7(2):214-9. PubMed ID: 3351706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.
    Laiho KM; Gavin J; Murphy JL; Connett GJ; Wootton SA
    Clin Nutr; 2004 Jun; 23(3):347-53. PubMed ID: 15158298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations.
    Walters MP; Littlewood JM
    J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):296-300. PubMed ID: 9740200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of fat absorption in cystic fibrosis patients and controls by a rapid micro procedure: a comparison with fecal fat excretion method.
    Kutty KM; Bridger H; Vaze D; Davis AJ
    Clin Biochem; 1983 Oct; 16(5):303-5. PubMed ID: 6652887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.
    Stallings VA; Tindall AM; Mascarenhas MR; Maqbool A; Schall JI
    PLoS One; 2020; 15(5):e0232685. PubMed ID: 32384122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.